Knight Therapeutics Inc. ( KHTRF) - Key Metrics
KHTRF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.34 | $0.09 | $0.35 | $0.34 |
| 2025Q3 | $1.22 | -$0.04 | $0.11 | $0.10 |
| 2025Q2 | $1.08 | -$0.13 | $0.20 | -$0.05 |
| 2025Q1 | $0.88 | $0.02 | $0.04 | $0 |
KHTRF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 16.94 |
| 2025Q3 | ? | -38.64 |
| 2025Q2 | ? | -11.50 |
| 2025Q1 | ? | 70.11 |
KHTRF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 5.11% | ? |
| 2025Q4 | 5.70% | ? |
| 2025Q3 | 1.66% | ? |
| 2025Q2 | -0.85% | ? |
| 2025Q1 | -0.01% | ? |
KHTRF
Price: $6.11
52 week price:
Earnings Per Share: 0.04 USD
P/E Ratio: 158.75
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 587.2 million